Circulating tumor DNA (ctDNA) in nonmetastatic colorectal cancer (CRC): Potential role as a screening tool.

Authors

Jeanne Tie

Jeanne Tie

Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Jeanne Tie , Yuxuan Wang , Isaac Kinde , Malcolm Steel , Hany Elsaleh , Madhu Sudan Singh , Natalie Heather Turner , Ben Tran , Robert Strausberg , Luis A. Diaz Jr., Nickolas Papadopoulos , Kenneth W. Kinzler , Bert Vogelstein , Peter Gibbs

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Prevention, Diagnosis, and Screening

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 518)

DOI

10.1200/jco.2015.33.3_suppl.518

Abstract #

518

Poster Bd #

A12

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer.

A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer.

First Author: Michael H. Storandt

First Author: Erin L. Symonds

Poster

2016 Gastrointestinal Cancers Symposium

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennaryN-glycan as a novel tumor marker for colorectal cancer.

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennaryN-glycan as a novel tumor marker for colorectal cancer.

First Author: Eiji Shinozaki